PFHO · XBRL financial data

Pacific Health Care Organization financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (PFHO's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	6,043	5,403	5,745	5,630	6,065	6,715
General and administrative	696	658	706	553	734	767
Total operating expenses	5,222	4,887	5,079	4,951	5,213	5,714
Operating income (loss)	820	516	666	679	853	1,001
Interest income	—	0	27	406	—	—
Interest expense	—	—	—	0	4	2
Income tax expense (benefit)	271	201	200	321	380	507
Net income (loss)	550	995	493	768	884	1,388
Earnings per share, basic USD per share	0.04	0.08	0.04	0.06	0.07	0.11
Earnings per share, diluted USD per share	0.04	0.08	0.04	0.06	0.07	0.11
Weighted average shares, basic thousands of shares	12,800	12,800	12,800	12,800	12,800	12,800
Weighted average shares, diluted thousands of shares	12,816	12,816	12,816	12,816	12,816	12,816

Fiscal years (PFHO's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	9,498	10,085	2,036	2,566	2,070	2,169
Accounts receivable	1,063	928	935	1,053	1,029	1,006
Total current assets	10,648	11,143	11,898	11,683	12,335	13,388
Property and equipment, net	123	93	97	77	52	52
Right-of-use asset	309	70	50	56	0	—
Total assets	11,107	11,333	12,052	11,824	12,433	13,463
Accounts payable	80	45	263	160	148	228
Accrued liabilities	275	315	333	368	423	127
Total current liabilities	1,043	501	709	1,008	746	389
Lease liability, non-current	66	0	11	12	0	—
Total liabilities	1,278	508	735	1,020	746	—
Retained earnings	9,401	10,396	10,888	10,375	11,258	12,646
Total stockholders' equity	9,829	10,824	11,317	10,804	11,687	13,075
Total liabilities and equity	11,107	11,333	12,052	11,824	12,433	13,463
Common shares outstanding (cover page) thousands of shares	12,800	12,800	12,800	12,800	12,800	12,800

Fiscal years (PFHO's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	550	995	493	768	884	1,388
Depreciation and amortization	55	49	34	38	34	24
Net cash from operating activities	987	386	711	932	675	1,161
Purchases of property and equipment	54	18	39	18	9	23
Net cash from investing activities	(54)	(18)	(8,760)	807	(1,134)	(990)
Dividends paid	—	—	0	1,210	0	37
Net cash from financing activities	461	219	0	(1,210)	35	(72)

SIC 8090 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8090 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Pacific Health Care Organization	2,653	1,513	507*	12.8M	—	Q3 FY26 10-QSep 30, 2026
BioCorRx	21	88	(440)*	29.8M	0.0 quarters	Q2 FY26 10-QJun 30, 2026
AnTix Holdings	14	not reported	not reported	70.7M	—	Q4 FY25 10-KJun 30, 2025
Marpai	138	4,166	(4,099)*	26.8M	0.0 quarters	Q2 FY26 10-QJun 30, 2026
BioRestorative Therapies	3,113	23	(3,808)	25.5M	0.9 quarters	Q1 FY26 10-QMar 31, 2026
Mangoceuticals	229	69	(261)*	21.6M	0.9 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.